Longitudinal association between markers of liver injury and mortality in COVID‐19 in China

Fang Lei, Ye Liu, Feng Zhou, J. Qin, P. Zhang, Lihua Zhu, Xiao-jing Zhang, Jingjing Cai, Lijin Lin, Shan Ouyang, Xiaoming Wang, Chengzhang Yang, Xu Cheng, Wei-fang Liu, H. Li, Jing Xie, B. Wu, Huiming Luo, F. Xiao, J. Chen, L. Tao, G. Cheng, Zhi‐Gang She, Jianghua Zhou, Haitao Wang, Jun Lin, Peng-Cheng Luo, Shouzhi Fu, Jihui Zhou, P. Ye, B. Xiao, W. Mao, Liming Liu, You-qin Yan, L. Liu, Guohua Chen, Hongliang Li, Xiaodong Huang, Bing-Hong Zhang, Yufeng Yuan

Hepatology, 2020

Coronavirus disease 2019 (COVID‐19) is a new infectious disease. To reveal the hepatic injury related to this disease and its clinical significance, we conducted a multicenter retrospective cohort study that included 5,771 adult patients with COVID‐19 pneumonia in Hubei Province.

Cited by 109 publications.

Field of study: Medicine

10.1002/hep.31301